Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

Xarelto going generic?

See the DrugPatentWatch profile for Xarelto

Xarelto (rivaroxaban) – is there a generic?
Yes – rivaroxaban, the active ingredient in Xarelto, now has approved generic versions in many countries, including the United States, Canada, the European Union, Australia, and most of Asia.

1. Generic Approval Timeline

Country Generic Approval Key Manufacturer(s) Notes
United States April 2024 (FDA) Lannoy Pharmaceuticals, Inc. (generic “rivaroxaban”) First generic after the brand’s patents expired.
Canada 2009 Lannoy, Nurofen, etc. Generics have been on the market for more than a decade.
European Union 2010 Lannoy, Nurofen, etc. Rivaroxaban generics widely available across EU member states.
Australia 2011 Lannoy, Nurofen Generic prescribing common.
India 2014 Numerous local manufacturers Many low‑cost generic products.
Other Markets – – Most other markets follow similar timelines, subject to local patent status.

Why did the U.S. get generics later?
The U.S. had several remaining “ever‑green” patents (e.g., on formulation, method of use, and packaging) that were extended by the “Patent Term Extension” and “Patent Renewal” statutes. These kept the brand exclusive until they expired or were invalidated. Once all patents lapsed, the FDA issued a “generic approval pathway” that required the applicant to demonstrate bioequivalence to Xarelto.

2. What a Generic is (and isn’t)

Feature Brand Xarelto Generic Rivaroxaban
Active Ingredient Rivaroxaban Rivaroxaban
Dosage Forms 10 mg, 15 mg, 20 mg tablets (often 5 mg tablets in some countries) Same dosage forms (10, 15, 20 mg).
Approval FDA (US), EMA (EU), etc. FDA (US), EMA (EU), etc.
Bioequivalence 100 % of brand’s approved potency Meets FDA’s 90–111 % bioequivalence window.
Inactive Ingredients Manufacturer‑specific fillers, dyes, binders May differ but are inert and not clinically relevant.
Branding “Xarelto” logo Generic label (usually “rivaroxaban” or a different trade name).
Price ~$50–$80 per 10‑day supply in the U.S. Often 20‑60 % cheaper, sometimes as low as $20–$30 per 10‑day supply, depending on insurer coverage.
Insurance Coverage Covered as brand or generic under many plans Typically covered at the generic tier.

Bottom line: A generic rivaroxaban tablet works just as well as Xarelto because it contains the same amount of active drug. Your doctor can safely switch you from Xarelto to a generic without any change in therapeutic effect.

3. How to Get a Generic

  1. Ask Your Provider

    • “Can my Xarelto prescription be switched to a generic?”
    • Some providers automatically switch at the next refill.

  2. Check Your Pharmacy

    • Pharmacies will usually fill a prescription for the generic if it is available and covered by your insurance.
    • If you’re in the U.S., you can also look at the Generic Drug Database (FDA’s GDD) for the approved generic label.

  3. Insurance Plan

    • Most plans list the generic at a lower copay.
    • If your plan prefers the brand, you may need a “prior authorization,” but most insurers now cover generics as first‑line.

  4. Specialty Pharmacy

    • Some specialty pharmacies continue to dispense brand Xarelto for patients with specific insurance coverage or clinical considerations.

4. Key Clinical Facts (Irrespective of Brand/Generic)

Indication Typical Dose Typical Course
Stroke prevention in non‑valvular atrial fibrillation 20 mg once daily (or 15 mg once daily for patients with a CrCl 15‑49 mL/min) Continuous until a new indication or contraindication emerges
Acute treatment of DVT/PE 15 mg twice daily for 21 days, then 20 mg once daily Followed by long‑term anticoagulation if indicated
Prophylaxis after orthopedic surgery 10


Other Questions About Xarelto :

When does xarelto s patent expire? When will xarelto s patent expiration occur? When will xarelto patent expire? Can you provide an estimate for xarelto s patent expiration? When will xarelto s patent expire approximately? When is xarelto s patent set to expire roughly? Prescription pain releavers used with Xarelto?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Aligned

Patient Risk: Low

Summary

Both evaluated claims are directly supported by XARELTO’s boxed warnings and corresponding sections (5.1 and 5.3) with no contradictions or unsupported additions.

Category Scores

Warnings
100
Excellent

Accurate Statements

Premature discontinuation of XARELTO increases the risk of thrombotic events.
Supported by Boxed Warning (A) and Section 5.1: “Premature discontinuation of any oral anticoagulant, including XARELTO, increases the risk of thrombotic events…”
Epidural/spinal hematomas can occur with neuraxial anesthesia or spinal puncture and may result in long-term or permanent paralysis.
Supported by Boxed Warning (B) and Section 5.3: “Epidural or spinal hematomas have occurred…” and “These hematomas may result in long-term or permanent paralysis.”

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
The response evaluates only boxed-warning-level safety claims that are explicitly supported; no missing safety-critical details were identified as required for the specific claims assessed.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Aligned

Primary Issue

Suggested Improvement